These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18316499)

  • 1. Pathophysiology of congenital heart disease in the adult, part II. Simple obstructive lesions.
    Rhodes JF; Hijazi ZM; Sommer RJ
    Circulation; 2008 Mar; 117(9):1228-37. PubMed ID: 18316499
    [No Abstract]   [Full Text] [Related]  

  • 2. Stent implantation as effective treatment of vascular stenosis in young infants with congenital heart disease: acute implantation and follow-up.
    Moodie D
    Catheter Cardiovasc Interv; 2008 May; 71(6):842. PubMed ID: 18412083
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathophysiology of congenital heart disease in the adult: part III: Complex congenital heart disease.
    Sommer RJ; Hijazi ZM; Rhodes JF
    Circulation; 2008 Mar; 117(10):1340-50. PubMed ID: 18332279
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathophysiology of congenital heart disease in the adult: part I: Shunt lesions.
    Sommer RJ; Hijazi ZM; Rhodes JF
    Circulation; 2008 Feb; 117(8):1090-9. PubMed ID: 18299514
    [No Abstract]   [Full Text] [Related]  

  • 5. Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the Management of Adults with Congenital Heart Disease--Part II.
    Therrien J; Gatzoulis M; Graham T; Bink-Boelkens M; Connelly M; Niwa K; Mulder B; Pyeritz R; Perloff J; Somerville J; Webb GD
    Can J Cardiol; 2001 Oct; 17(10):1029-50. PubMed ID: 11694894
    [No Abstract]   [Full Text] [Related]  

  • 6. Congenital heart defects in children. Part 1 of a 2-part series: anatomical anomalies & their resultant pathophysiology.
    Mazurek P
    JEMS; 2004 Jan; 29(1):38-40, 42-8, 51-3. PubMed ID: 14735097
    [No Abstract]   [Full Text] [Related]  

  • 7. [Congenital heart diseases in adults].
    Vestri A; D'Intino S; Reale A
    Boll Soc Ital Cardiol; 1975; 20(9):1059-61. PubMed ID: 1233056
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary arterial hypertension in congenital heart diseases.
    Beghetti M; Tissot C
    Semin Respir Crit Care Med; 2009 Aug; 30(4):421-8. PubMed ID: 19634081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease.
    Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L
    Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in congenital heart disease: should a woman be more like a man?
    Warnes CA
    Circulation; 2008 Jul; 118(1):3-5. PubMed ID: 18591448
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors of supraventricular arrhythmia in adults with congenital heart disease.
    Trojnarska O; Grajek S; Kramer L; Gwizdała A
    Cardiol J; 2009; 16(3):218-26. PubMed ID: 19437395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiodromes: using recognizable sets of signs & symptoms to understand & manage congenital heart defects.
    Goss JF; Cobos C; Gerard S; Navis C
    JEMS; 2009 Jun; 34(6):60-7. PubMed ID: 19539138
    [No Abstract]   [Full Text] [Related]  

  • 14. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator.
    Silka MJ; Bar-Cohen Y
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):298-306. PubMed ID: 19808422
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral obstructive artery disease: a pathophysiological and clinical overview.
    Di Perri T
    Ann Ital Med Int; 1986; 1 Suppl 1():24-6. PubMed ID: 3079435
    [No Abstract]   [Full Text] [Related]  

  • 16. The next frontier in cardiovascular developmental biology--an integrated approach to adult disease?
    Markwald RR; Butcher JT
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):60-1. PubMed ID: 17245398
    [No Abstract]   [Full Text] [Related]  

  • 17. Right-to-left intracardiac shunt in obstructive lung disease.
    Berglund E
    Eur J Respir Dis; 1981 Dec; 62(6):371-2. PubMed ID: 7347687
    [No Abstract]   [Full Text] [Related]  

  • 18. [Congenital cardiopathies in adult age. A growing problem. A new "subspecialty"?].
    Almange C
    Arch Mal Coeur Vaiss; 1999 May; 92(5):553-5. PubMed ID: 10367070
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital heart disease in Nepalese children.
    Basnet NB
    JNMA J Nepal Med Assoc; 2006; 45(162):281-2. PubMed ID: 18365359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling in congenital heart disease. Art or science?
    Giannakoulas G; Dimopoulos K; Xu XY
    Int J Cardiol; 2009 Apr; 133(2):141-4. PubMed ID: 19046780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.